19 Hrs
Source:
Financial Times
Novo acquires Chinese weight-loss pill rights
Hengrui Pharma announced that its new drug could potentially be administered once a week. The development aims to improve patient convenience and adherence. Further details on approval or specific indications were not provided.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)